Comparative Study of Carboplatin Dosing in Lung Cancer Patients ...

In this study, the doses of carboplatin calculated by the Calvert formula based on estimated GFRs with various GFR equations were compared with the doses of ...

Comparative Study of Carboplatin Dosing in Lung Cancer Patients. Using the Calvert Formula and Four Equations for. Estimating Glomerular Filtration Rate. Seo ...

Carboplatin dose calculations for patients with lung cancer

Carboplatin is the backbone cytotoxic agent for many chemotherapy regimens for lung cancer. Dosing of carboplatin is complicated due to its ...

Comparative Study of Carboplatin Dosing in Lung Cancer Patients ...

Comparative Study of Carboplatin Dosing in Lung Cancer Patients Using the Calvert Formula and Four Equations for Estimating Glomerular Filtration Rate.

A comparison of methods of calculation for estimating carboplatin ...

The effect remained highly significant after adjustment for treatment arm. We conclude that for a moderate carboplatin dose in non-small cell lung cancer, the ...

Comparative Study of Carboplatin Dosing in Lung Cancer Patients ...

Request PDF | On Apr 30, 2020, Seo Won Kim and others published Comparative Study of Carboplatin Dosing in Lung Cancer Patients Using the Calvert Formula ...

A comparison of methods of calculation for estimating carboplatin ...

... dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer ... Retrospective analysis of the carboplatin dosage and relationship ...

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer ...

Findings In this cohort study of 4408 patients at US Veteran Affairs hospitals, there was no significant difference in overall survival (OS) ...

Comparative analysis of carboplatin and paclitaxel combination ...

The combination of carboplatin and paclitaxel is one of the most commonly used regimens for the treatment of non‑small cell lung cancer ...

Efficacy Comparison Between Weekly and Triweekly Regimens of ...

We demonstrated that weekly CP treatment, which is known to have fewer toxicity in NSCLC, provided better PFS compared to triweekly treatment.

Efficacy and safety of first-line carboplatin-versus cisplatin-based ...

... lung cancer (NSCLC): PIvOTAL study. Eur. J ... comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer.

Efficacy and safety of carboplatin with nab-paclitaxel versus ...

Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, ...

Adjustment of creatinine clearance for carboplatin dosing in ...

Crude eCCr values were significantly different between both groups (71.2 vs. 79.0, p = 0.018). The proportion of patients treated with ...

Phase III randomised trial comparing paclitaxel/carboplatin with ...

In the meta-analysis undertaken by the Non-Small-Cell Lung Cancer Collaborative Group, a hazard ratio of 0.73 was observed (27% reduction in the risk of death ...

Comparison of Carboplatin Plus Pemetrexed Followed by ...

Progression-free survival was also significantly longer in patients who received the combination of carboplatin and pemetrexed than in those who ...

A randomized study comparing cisplatin or carboplatin with ...

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research ...

Dose escalation study of carboplatin–pemetrexed followed by ...

... patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC). Patients and methods. Patients received escalated doses of carboplatin and pemetrexed ...

Carboplatin versus two doses of cisplatin in combination with ...

Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non–small cell lung cancer. J Clin ...

a randomized phase II study of combination chemotherapy against ...

Paclitaxel (Taxol) plus carboplatin (PC) has shown activity in the treatment of advanced non-small-cell lung cancer (NSCLC).

Comparative Study of Carboplatin Dosing in Lung Cancer Patients ...

Comparative Study of Carboplatin Dosing in Lung Cancer Patients Using the Calvert Formula and Four Equations for Estimating Glomerular Filtration Rate ...